GLYCOPYRROLATE INJECTION, USP 0.2MG/ML, 1mL VIAL, manufactured by HF Acquisition Co. LLC, Mukilteo, WA 98275, NDC 51662-1487-3

FDA recall notice · announced June 14, 2023 · Hf Acquisition Co

Class III FDA/FSIS Class III: use is not likely to cause adverse health consequences.

The product

GLYCOPYRROLATE INJECTION, USP 0.2MG/ML, 1mL VIAL, manufactured by HF Acquisition Co. LLC, Mukilteo, WA 98275, NDC 51662-1487-3

Reason for recall

Labeling: Label Mix-up

Notes

Distribution: Distributed in TX, AZ and CA only
Lot/code information: Lot #: 2205095.1, Exp. Date 7/31/2024
Quantity: 9 boxes of 25 vials
Status: Terminated
Products in this recall event:
- GLYCOPYRROLATE INJECTION, USP 0.2MG/ML, 1mL VIAL, manufactured by HF Acquisition Co. LLC, Mukilteo, WA 98275, NDC 51662-1487-3 (D-0870-2023)

Source: U.S. Food and Drug Administration public recall data. This page reports official records and is not legal, medical, or repair advice.